Cart
sales@molnova.com
Pipoxizine
CAS No. 55837-21-3
Pipoxizine( —— )
Catalog No. M36111 CAS No. 55837-21-3
Pipoxizine has an antagonistic effect on histamine-induced bronchoconstriction and may be used in the study of asthma disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 247 | In Stock |
|
| 10MG | 371 | In Stock |
|
| 25MG | 620 | In Stock |
|
| 50MG | 863 | In Stock |
|
| 100MG | 1172 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2353 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePipoxizine
-
NoteResearch use only, not for human use.
-
Brief DescriptionPipoxizine has an antagonistic effect on histamine-induced bronchoconstriction and may be used in the study of asthma disease.
-
DescriptionPipoxizine has an antagonistic effect on histamine-induced bronchoconstriction and may be used in the study of asthma disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number55837-21-3
-
Formula Weight381.51
-
Molecular FormulaC24H31NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=C1CCN(CCOCCOCCO)CC1)(C2=CC=CC=C2)C3=CC=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
H-Phe(4-Cl)-D-Cys-β-...
PRL 3195 is a somatostatin receptor antagonist with Kis of 6, 17, 66, 1000 and 1000 nM for human somatostatin receptors (sst5, sst2, sst3, sst1 and sst4, respectively).
-
16-anhydro-b-D-Gluco...
16-anhydro-b-D-Glucose (Levoglucosan) is an anhydrohexose that is the 16-anhydro-derivative of beta-D-glucopyranose. It is formed from the pyrolysis of carbohydrates such as starch and cellulose. Levoglucosan can also be utilized in the synthesis of chiral polymers such as unhydrolysable glucose polymers.
-
PLP 139-151
PLP (139-151) is amino acid residue residue 139 to 151 of myelin proteolipid protein (PLP). This peptide is used to induce relapsing-remitting (RR)-EAE model.
